Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study page no longer displays the MedlinePlus Genetics-related Type 2 diabetes topic entry. The trial’s study details remain unaffected.
    Difference
    0.2%
    Check dated 2026-11-15T14:30:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a Phase 4 study of dapagliflozin added to metformin for people with type 2 diabetes, with details on its design, eligibility, outcomes, and location, replacing the error page.
    Difference
    50%
    Check dated 2026-11-08T14:11:53.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2; the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:38:04.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A notice about NIH websites transitioning from the term “Artificial Intelligence” to “Super Intelligence” appears above the study record page, which still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T14:28:47.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:08:01.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:26.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.